ARMISTICE CAPITAL, LLC

Q4 2024 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
12/31/2024
Date filed
2/14/2025
Form type
13F-HR
Num holdings
232
Total value ($000)
$7,329,986
Net value change ($000)
+1,077,335 (17.2%)
New positions
56
Sold out positions
90
Turnover %
18.4%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 11/14/2024 Next filing: 5/15/2025 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q3 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
NBIX 100,859 482.6%
EXAS 90,859 NEW
ICLR 87,682 NEW
VRTX 68,757 320.5%
GSK 59,003 275.4%
MNST 28,960 2988.6%
SNY 26,766 80.1%
CENT 26,300 NEW
FIVN 26,172 48.6%
ENR 23,354 209.1%
Top Reduces (Value $000, Stocks/ETFs)
ALKERMES PLC -40,548 -100.0%
CYTK -38,423 -38.4%
DOCU -25,016 -100.0%
AGIO -23,655 -24.1%
INCY -23,059 -15.9%
SHAK -22,778 -48.6%
DPZ -22,590 -51.9%
PARAV -21,240 -100.0%
MRK -20,758 -100.0%
TFX -19,291 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 3,029,862 (41.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None